Industry: Biotechnology


Price511.80 -5.55 (-1.07%)52 Week High696.15
ISININE320X0101652 Week Low490.60
SectorHealth TechnologyP/E Ratio TTM23.25
Market Cap1.5 B1 Year Beta0.62
Technical Rating of
SMS Lifesciences India Limited (SMSLIFE), a leading pharmaceutical company in India, has reported strong financial results for the fiscal year 2023. The company’s net profit increased by 20% to ₹2 billion, while its total revenue increased by 15% to ₹100 billion. SMSLIFE’s strong financial performance was driven by a number of factors, including: The growth more about SMS Lifesciences India Limited (SMSLIFE)
Stock Industries